A company focused on developing and commercializing innovative new therapies in dermatology
- Year invested 2011
- Investment Stage Early
- Sectors
- Investment Status Historic
- Website dermira.com
- Company Status IPO/Acquired (by Lilly) (NASDAQ: DERM)
A company focused on developing and commercializing innovative new therapies in dermatology